Collectively, these clinical gene expression data showed that the overexpression of POLR3G in triple-negative breast cancer is not part of a general overexpression program concerning the entire Pol III transcription machinery, but rather a gene-specific regulation of this particular subunit in this type of breast cancer. The gene discussed is POLR3G; the disease is breast carcinoma.